In conclusion, our study demonstrated that endothelial angiopoietin-2 expression is the only independent predictor of post-liver transplant tumor recurrence, compared to other relevant characteristics of tumor aggressiveness such as tumor size HCC and/or presence of residual viability of the tumor nodule at explant. This evidence concerns the gene ANGPT2 and neoplasm.